Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Erixon Läkarkonsult AB
AB
Active
Org 5568203482
Klapparvik 706
Other human health activities n.e.c. · NACE 8699
Est. 2010
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
SEK 261K
+93% vs 2024
EBITDA margin
98.0%
+90% vs 2024
Equity ratio
53.9%
Financial strength
Net profit 2025
SEK 141K
+53% vs 2024
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
SEK 261K
+93%
EBITDA
SEK 256K
+90%
Net profit
SEK 141K
+53%
Total assets
SEK 355K
+92%
Equity
SEK 191K
+35%
Employees
1
—
Company information
Legal name
Erixon Läkarkonsult AB
Org number
5568203482
Legal form
Aktiebolag
NACE code
8699 · Other human health activities n.e.c.
Founded
1 oktober 2010
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Föremål för bolagets verksamhet är medicinsk rådgivning och konsultverksamhet och därmed förenlig verksamhet.
Contact
Address
Klapparvik 706
Email
peter.erixon@live.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Other human health activities n.e.c.
Companies in Söderhamn
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
225
283
195
135
261
Staff expenses
—
−0
−2
−0
−5
EBITDA
212
283
193
135
256
Depreciation & amort.
−0
—
—
—
—
EBIT
212
272
178
116
239
Net financials
—
−0
−1
−0
0
Profit before tax
212
272
178
116
179
Tax
−44
−56
−37
−25
−38
Net profit
168
216
141
92
141
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
232
356
246
185
355
Equity
218
266
191
142
191
Long-term debt
0
—
—
—
—
Short-term debt
14
91
55
43
103
Total debt
14
91
55
43
103
Financial ratios
5-year trend
EBITDA margin
98.0%
This company
15.8%
Market median
+520% vs market
2021
2025
Equity ratio
53.9%
This company
38.2%
Market median
+41% vs market
2021
2025
Return on equity
73.5%
This company
18.4%
Market median
+299% vs market
2021
2025
Net profit margin
53.9%
This company
8.1%
Market median
+565% vs market
2021
2025
Asset turnover
0.74×
This company
1.12×
Market median
-34% vs market
2021
2025
Debt / equity
0.85×
This company
0.62×
Market median
+37% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
RT
Rolf Thomas Erixon
Deputy Board Member
2022
LP
Lars Peter Erixon
Board of Directors
2022
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Erixon Läkarkonsult AB also hold positions in
0
other companies.
Person
Role here
Other companies
Rolf Thomas Erixon
Deputy Board Member
0 companies
Lars Peter Erixon
Board of Directors
0 companies